Dr Gael Morrow

Skip to main content

Research Repository

Understanding the beneficial and harmful effects of Tranexamic Acid to treat traumatic haemorrhage Oct 1, 2024 - Sep 30, 2025
Traumatic injury accounts for 4.9 million deaths worldwide each year. Approximately 25% of trauma patients die within 6 h of injury from uncontrolled bleeding, termed trauma induced coagulopathy (TIC). TIC describes the overall failure of the blood c... Read More about Understanding the beneficial and harmful effects of Tranexamic Acid to treat traumatic haemorrhage.

Binding affinity of different commercial FIX therapies to collagen IV Oct 1, 2023 - Nov 30, 2024
Haemophilia B is a blood clotting disorder caused by deficiency of blood coagulation Factor IX (FIX), resulting in bruising and bleeding. Haemophilia B affects 1:30,000 males in the UK and is treated by infusion of FIX concentrate to sustain normal f... Read More about Binding affinity of different commercial FIX therapies to collagen IV.

How do fresh whole blood and blood component therapies containing additive solutions alter the structure and stability of a blood clot during traumatic bleeding? Dec 1, 2023 - Nov 30, 2024
In a military setting, bleeding is the primary cause of preventable death in patients suffering from polytrauma and massive haemorrhage. Access to hospital care and blood products is limited by location, logistics and personnel. Pre-hospital blood in... Read More about How do fresh whole blood and blood component therapies containing additive solutions alter the structure and stability of a blood clot during traumatic bleeding?.